Cargando…
Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling
BACKGROUND: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selecti...
Autores principales: | Liu, Na, He, Song, Ma, Li, Ponnusamy, Murugavel, Tang, Jinhua, Tolbert, Evelyn, Bayliss, George, Zhao, Ting C., Yan, Haidong, Zhuang, Shougang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546966/ https://www.ncbi.nlm.nih.gov/pubmed/23342059 http://dx.doi.org/10.1371/journal.pone.0054001 |
Ejemplares similares
-
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
por: Yan, Yanli, et al.
Publicado: (2016) -
Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation
por: Li, Jialu, et al.
Publicado: (2022) -
Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression
por: Yu, Chao, et al.
Publicado: (2021) -
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
por: Xiong, Chongxiang, et al.
Publicado: (2016) -
EGFR signaling in renal fibrosis
por: Zhuang, Shougang, et al.
Publicado: (2014)